Amyloid alone does not confirm that Alzheimer's disease is progressing rapidly. Here's what people need to know about the ...

Offering a simpler alternative to PET scans and CSF analysis, blood-based biomarker tests could improve accessibility of ...

Weill Cornell Medicine researchers have received a five-year $6.2 million grant from the National Institute on Aging, part of the National Institutes of Health, to build a portable, high-resolution ...

Some researchers seek to establish a single abnormal result on a set of biomarker-based tests as sufficient to diagnose the ...

The memorandum of understanding (MOU) between the companies aims to advance the development of imaging agents used in PET ...

King Faisal Specialist Hospital & Research Centre (KFSHRC) and Eli Lilly Saudi Arabia Limited (Lilly) have signed a ...

The ability to possibly detect Alzheimer’s disease before symptoms emerge using blood-based biomarkers has introduced new ...

Blood-based diagnostic tests are gaining traction as a potential method for the early detection of Alzheimer’s disease, ...

While early detection of Alzheimer’s disease is crucial for better outcomes, a report on Wednesday said that blood-based ...

When I co-invented the first PET (positron emission tomography) scan to visualize brain amyloid and tau—the physical evidence of Alzheimer’s disease—I did not foresee the distressing mental ...

The signing of a Memorandum of Understanding (MoU) between King Faisal Specialist Hospital & Research Centre (KFSHRC) and Eli Lilly Saudi Arabia Limi ...

Eli Lilly Saudi Arabia and King Faisal Specialist Hospital & Research Centre (KFSHRC) have teamed up to make KFSHRC’s Neuroscience Centre a top regional hub for Alzheimer’s disease treatment.